News for Healthier Living
First of Its Kind Gene Therapy Model Offers Hope for X-Linked Sideroblastic Anemia Treatment
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine pioneered a first of its kind gene therapy model that offers a potential breakthrough in treating X-linked sideroblastic anemia (XLSA), a rare congenital anemia caused by mutations in the ALAS2 gene crucial for the synthesis of heme, a key compound in hemoglobin.
January 2, 2025
January 4 2025January 3 2025January 2 2025January 1 2025December 31 2024December 30 2024December 29 2024December 28 2024December 27 2024December 26 2024December 24 2024December 23 2024
|
|
|
|
|